Letter · 25 Nov 2020
Case reportPublished 28 Apr 2021
Coronavirus disease 2019 (COVID-19) an emerging trigger for primary fibromyalgia syndrome: A tale of three cases post-COVID-19
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Corona virus (COVID-19) is an emerging worldwide infectious disease that may be followed in some patients by post COVID-19 syndrome; patients who experience symptom of disease long time after their recovery. Among the frequent post-COVID-19 symptoms are fatigue, headache, sleep disorder, anxiety and musculoskeletal pain which coincide with features of Fibromyalgia Syndrome (FMS). This study reports out of the ordinary scenarios and outcomes for three cases who developed primary FMS post COVID-19. Method: Three females, not known to have previous FMS or any other rheumatic disease, post COVID-19 were referred for rheumatology consultation due to the prolonged persistence of symptoms after recovery from COVID-19. Results: The cases presented with anxiety and depression, headache, generalized musculoskeletal pain, paresthesia and non-restorative sleep. General examination and various laboratory investigation including autoimmune profile as well as radiological investigation were all normal. Tender points on examination lead to the diagnosis of FMS. Non-pharmacological and pharmacological management with antidepressant therapy were prescribed with improvement. Conclusions: We are presenting the first three cases of COVID-19 infection as an emerging trigger for FMS. This association should be considered during management of post COVID-19 syndrome to improve pain care and prevent worsening of symptom during the COVID-19 pandemic.
Subjects
RheumatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 6 Feb 2017
Does a Three Week's Treatment with Microcurrents Improve the FunctionalLevel of People with Fibromyalgia Syndrome?
Research article · 24 Jun 2022
Comprehensive Biotechnical System for Screening Risk-Based Diagnosis of COVID-19 and Post-COVID Syndrome
Research article · 29 Jul 2020
Treatment outcome of primary Fibromyalgia Syndrome (FMS) using Duloxetine versus Pregabalin & Nortriptyline- An observational study
Conference abstract · 22 Feb 2021
COVID-19 as a trigger of recurrent Guillain-Barre Syndrome
More from this journal
The newest in International Journal of Clinical Rheumatology.
Article · 27 Feb 2026
Ultrasound assessments of lower extremity joint structures from astronauts after 18 days on board the International Space Station
Article · 27 Feb 2026
Ultrasound assessments of lower extremity joint structures from astronauts after 18 days on board the International Space Station
Article · 30 Dec 2025
Genomics in Autoimmune Disease: Unraveling Genetic Contributions and Personalized Approaches
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInternational Journal of Clinical Rheumatology
- SubjectRheumatology
- BylineArticles whose byline prints “Tamer A Gheita”
- BylineArticles whose byline prints “Hanan M Fathi”
- BylineArticles whose byline prints “Suzan S ElAdle”
